-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Re: Another Interesting VBAC From: Dean Huffman (jth@springnet1.com) Sun Jul 16 09:36:48 2000 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: Joanne Bulley, MD: "Re: TVT procedure and high residual urines" Previous message: Ron Jewell: "TVT procedure and high residual urines" Next in thread: art fougner, md: "Re: Another Interesting VBAC" Reply: art fougner, md: "Re: Another Interesting VBAC" The issue of labeling of terbutaline apparently has been quite an issue for quite some time. A few years ago (I will try to find it) there was an interesting article by Hugh Barber on the issue. It seems that the drug companies have been fighting tooth and nail to put that wording in and have it stay there. I do not know how big a market IV terbutaline is for tocylysis, but it was certainly a big enough market for a company to make Yutopar. In any event, with the labeling as such, the drug companies can sell terbutaline for tocolysis as much as they want, and take the profits, but if anything ever goes wrong, they can point to the package insert and tell the judge or jury that, "...it was that damn doctor that gave the terbutaline and he did not even look at the package insert. IT IS THE DOCTOR'S FAULT AND WE ARE COMPLETELY INNOCENT." -- Dean Huffman - - - - Re: Another Interesting VBAC From: Paul Prior MD (pprior@earthlink.net) Sun, 09 Jul 2000 12:58:19 -0400 On Sun, 9 Jul 2000 01:07:13 -0500, eramirez@icepr.com (Efrain Ramirez) wrote: >Terbutaline sulfate should not be used for tocolysis. Serious adverse >reactions may occur after administration ofterbutaline sulfate to women >in labor. In the >mother, theseinclude increased heart rate, transient >hyperglycemia,hypokalemia, cardiac arrhythmias,pulmonary edema, >andmyocardial ischemia. Increased >fetal heart rate andneonatal hypoglycemia may occur as a result of >maternal administration. > >DOSAGE AND ADMINISTRATION > >Ampuls should be used only for subcutaneous administration and not >intravenous infusion. Sterility and >accurate dosing cannot be assured if the ampuls are >not used inaccordance with DOSAGE AND ADMINISTRATION. Wow. I never read the package insert. Didn't realize they were this strong against it. Is this present on the PO version as well? (note: I do NOT use PO terbutaline!!) -- Paul Prior MD Get rebates on online purchases - up to 25% cash back. Ashland, KY USA Including Disney,Borders,DVDexpress,800.com,Dell, petstore Using Spamkiller iBaby, etoys, JCrew,800-flowers,PlanetRX,Avon & many more. so spam away... try: http://www.ebates.com/index.jhtml?referrer=pprior Next message: Joanne Bulley, MD: "Re: TVT procedure and high residual urines" Previous message: Ron Jewell: "TVT procedure and high residual urines" Next in thread: art fougner, md: "Re: Another Interesting VBAC" Reply: art fougner, md: "Re: Another Interesting VBAC"

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Dec 2 04:47:02 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.